KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Xenon Pharmaceuticals (XENE) Return on Assets (2016 - 2025)

Xenon Pharmaceuticals (XENE) has disclosed Return on Assets for 12 consecutive years, with 0.56% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Assets fell 26.0% to 0.56% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.56%, a 26.0% decrease, with the full-year FY2025 number at 0.48%, down 21.0% from a year prior.
  • Return on Assets was 0.56% for Q4 2025 at Xenon Pharmaceuticals, down from 0.49% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.13% in Q2 2022 to a low of 0.56% in Q4 2025.
  • A 5-year average of 0.25% and a median of 0.21% in 2024 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: increased 10bps in 2022, then fell -26bps in 2025.
  • Xenon Pharmaceuticals' Return on Assets stood at 0.19% in 2021, then rose by 13bps to 0.16% in 2022, then dropped by -30bps to 0.21% in 2023, then crashed by -38bps to 0.29% in 2024, then plummeted by -90bps to 0.56% in 2025.
  • Per Business Quant, the three most recent readings for XENE's Return on Assets are 0.56% (Q4 2025), 0.49% (Q3 2025), and 0.4% (Q2 2025).